Reviewing the Options for Treating MS
Multiple sclerosis (MS) symptoms vary widely among those with the disease. And that can complicate efforts to prescribe the right treatment for MS patients.
FDA Investigating Rare Brain Infection in Patient Taking Gilenya (fingolimod)
The US Food and Drug Administration (FDA) is alerting the public that a patient in Europe diagnosed with possible multiple sclerosis (MS) has developed a rare and serious brain infection after taking the drug Gilenya (fingolimod).